Literature DB >> 8612657

Kinetics of radioiodinated species in subcellular fractions from rat hearts following administration of iodine-123-labelled 15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (123I-BMIPP).

S Morishita1, H Kusuoka, Y Yamamichi, N Suzuki, M Kurami, T Nishimura.   

Abstract

It is recognized that iodine-123-labelled 15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (123I-BMIPP) slowly washes out of the myocardium. The mechanism for the washout was investigated in normal rat hearts by analyses of the subcellular distribution and lipid classes based on the BMIPP metabolism. Rat hearts were excised at 1-120 min after intravenous injection of 123I-BMIPP. After counting the radioactivity, the hearts were digested with Nagarse and homogenized, and then fractionated into the cytosolic, mitochondrial, microsomal and crude nuclear fractions by centrifugations. The radioactivity of each fraction was counted, and the lipid classes were analysed by radio-thin-layer chromatographic and high-performance liquid chromatographic methods. The heart uptake of 123I-BMIPP was maximal at 5 min (6.81%+/-0.36% ID/g), and 41% of the radioactivity disappeared within 120 min. The myocardial radioactivity was immediately distributed into the cytosolic, mitochondrial, microsomal and crude nuclear fractions. The distribution (%) of each fraction was almost identical from 5 min through 120 min. The cytosolic fraction was always the major site of radioactivity deposition (60%), and the time-activity curve of the cytosolic fraction paralleled that of the whole heart throughout the 120-min study period. In the cytosolic fraction, most of the radioactivity was incorporated into the triglyceride class, and the rest was present in the free fatty acid, phospholipid (phosphatidylcholine) and diglyceride classes. In the mitochondrial fraction, the radioactivity was mostly incorporated into the phospholipid class (phosphatidylethanolamine), followed by free fatty acids. The final metabolite of 123I-BMIPP, 123I-p-iodophenylacetic acid (123I-PIPA), initially appeared in the mitochondrial fraction as early as 1 min, and subsequently in the cytosolic fraction at 5 min. Another intermediary metabolite, 123I-p-iodophenyldodecanoic acid (123I-PIPC12), was found only in the mitochondrial fraction after 5 min. In conclusion, the slow washout kinetics of 123I-BMIPP from the myocardium mainly reflects the turnover rate of the triglyceride pool in the cytosol. The BMIPP metabolism, i.e. initial alpha-oxidation followed by subsequent cycles of beta-oxidation, was confirmed in vivo. The participation of the mitochondria in the metabolism was also proven.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612657     DOI: 10.1007/bf01247365

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  27 in total

1.  Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

Authors:  C DE DUVE; B C PRESSMAN; R GIANETTO; R WATTIAUX; F APPELMANS
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

2.  Cytochemical studies of mammalian tissues; isolation of intact mitochondria from rat liver; some biochemical properties of mitochondria and submicroscopic particulate material.

Authors:  G H HOGEBOOM; W C SCHNEIDER; G E PALLADE
Journal:  J Biol Chem       Date:  1948-02       Impact factor: 5.157

Review 3.  Experimental basis of metabolic imaging of the myocardium with radioiodinated aromatic free fatty acids.

Authors:  S N Reske; F F Knapp; C Winkler
Journal:  Am J Physiol Imaging       Date:  1986

4.  Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism.

Authors:  M Kawamoto; N Tamaki; Y Yonekura; E Tadamura; Y Fujibayashi; Y Magata; R Nohara; S Sasayama; K Ikekubo; H Kato
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

5.  Evidence for a particulate location of ubiquitin conjugates and ubiquitin-conjugating enzymes in rabbit brain.

Authors:  M Magnani; G Serafini; A Antonelli; M Malatesta; G Gazzanelli
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

6.  beta-Methyl-15-p-iodophenylpentadecanoic acid metabolism and kinetics in the isolated rat heart.

Authors:  T R DeGrado; J E Holden; C K Ng; D M Raffel; S J Gatley
Journal:  Eur J Nucl Med       Date:  1989

7.  Effects of fasting on the myocardial subcellular distribution and lipid distribution of terminal p-iodophenyl-substituted fatty acids in rats.

Authors:  K R Ambrose; B A Owen; A P Callahan; M M Goodman; F F Knapp
Journal:  Int J Rad Appl Instrum B       Date:  1988

8.  Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cardiomyopathy: assessment by radial long-axis SPET.

Authors:  S L Chen; T Uehara; T Morozumi; H Yamagami; H Kusuoka; T Nishimura
Journal:  Nucl Med Commun       Date:  1995-05       Impact factor: 1.690

9.  Radioiodinated 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid: a useful new agent to evaluate myocardial fatty acid uptake.

Authors:  F F Knapp; M M Goodman; A P Callahan; G Kirsch
Journal:  J Nucl Med       Date:  1986-04       Impact factor: 10.057

10.  Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of 99mTc-Sestamibi and 123I-beta-methyl-iodo-phenyl pentadecanoic acid.

Authors:  F De Geeter; P R Franken; F F Knapp; A Bossuyt
Journal:  Eur J Nucl Med       Date:  1994-04
View more
  11 in total

Review 1.  Future aspects of BMIPP.

Authors:  N Tamaki; K Morita; E Tsukamoto; Y Kawai
Journal:  Int J Card Imaging       Date:  1999-02

2.  Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method.

Authors:  K Saito; K Takeda; S Okamoto; R Okamoto; K Makino; Y Tameda; Y Nomura; H Maeda; T Ichihara; T Nakano
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

3.  Perfusion-BMIPP mismatch: specific finding or artifact?

Authors:  Koichi Morita; Eriko Tsukamoto; Nagara Tamaki
Journal:  Int J Cardiovasc Imaging       Date:  2002-08       Impact factor: 2.357

4.  Role of BMIPP imaging for risk stratification in patients with coronary artery disease.

Authors:  Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

Review 5.  beta-Methyl-p-(123I)-iodophenyl pentadecanoic acid single-photon emission computed tomography in cardiomyopathy.

Authors:  T Nishimura
Journal:  Int J Card Imaging       Date:  1999-02

Review 6.  Experimental evaluation of radiotracers: role of intact biological models.

Authors:  A J Sinusas
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

7.  Reduced 123I-BMIPP uptake implies decreased myocardial flow reserve in patients with chronic stable angina.

Authors:  Hiroyuki Kageyama; Koichi Morita; Chietsugu Katoh; Takahiro Tsukamoto; Kazuyuki Noriyasu; Megumi Mabuchi; Masanao Naya; Yuko Kawai; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07-23       Impact factor: 9.236

Review 8.  Delayed recovery of fatty acid metabolism after transient myocardial ischemia: a potential imaging target for "ischemic memory".

Authors:  Steven A Messina; Omer Aras; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2007-04       Impact factor: 2.931

9.  Relation between thallium-201/iodine 123-BMIPP subtraction and fluorine 18 deoxyglucose polar maps in patients with hypertrophic cardiomyopathy.

Authors:  Y Ito; S Hasegawa; H Yamaguchi; J Yoshioka; T Uehara; T Nishimura
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

10.  Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course.

Authors:  Y Yazaki; M Isobe; W Takahashi; H Kitabayashi; O Nishiyama; M Sekiguchi; T Takemura
Journal:  Heart       Date:  1999-02       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.